Δ9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 2, 2008, Pages 499-506

  Egashira, Nobuaki ^a,b   Ishigami, Noriko ^a   Mishima, Kenichi ^a   Iwasaki, Katsunori ^a   Oishi, Ryozo ^b   Fujiwara, Michihiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acetylcholine; Cannabinoids; Memory; Olanzapine; Radial arm maze

Indexed keywords

ACETYLCHOLINE; ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; OLANZAPINE; TETRAHYDROCANNABINOL; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; PSYCHEDELIC AGENT;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; MALE; MAZE TEST; NONHUMAN; RAT; SCHIZOPHRENIA; SPATIAL MEMORY; ANIMAL; ANIMAL BEHAVIOR; BIOSYNTHESIS; CANNABIS ADDICTION; CHEMICALLY INDUCED DISORDER; EXTRACELLULAR SPACE; HUMAN; MEMORY DISORDER; METABOLISM; MICRODIALYSIS; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BENZODIAZEPINES; COGNITION DISORDERS; EXTRACELLULAR SPACE; HALLUCINOGENS; HALOPERIDOL; HIPPOCAMPUS; HUMANS; MALE; MARIJUANA ABUSE; MAZE LEARNING; MEMORY DISORDERS; MICRODIALYSIS; RATS; RATS, WISTAR; TETRAHYDROCANNABINOL;

EID: 38749089850     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.10.001     Document Type: Article

References (36)

1. Bilder R.M., Goldman R.S., Volavka J., Czobor P., Hoptman M., Sheitman B., et al. Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry 159 (2002) 1018-1028
2. Braff D.L., Grillon C., and Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49 (1992) 206-215
3. Bymaster F.P., Calligaro D.O., Falcone J.F., Marsh R.D., Moore N.A., Tye N.C., et al. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14 (1996) 87-96
4. 9-tetrahydrocannabinol in rats. Brain Res 809 (1998) 1-4
5. 1A receptor agonism. Brain Res 1023 (2004) 54-63
6. 9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Res; 952 (2002) 239-245
7. 9-tetrahydrocannabinol-induced impairment of spatial memory. Eur J Pharmacol 445 (2002) 221-229
8. Elvevag B., and Goldberg T.E. Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol 14 (2000) 1-21
9. Emrich H.M., Leweke F.M., and Schneider U. Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 56 (1997) 803-807
10. Gessa G.L., Casu M.A., Carta G., and Mascia M.S. Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A. Eur J Pharmacol 355 (1998) 119-124
11. Hatip-Al-Khatib I., Iwasaki K., Yoshimitsu Y., Arai T., Egashira N., Mishima K., et al. Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats. Brit J Pharmacol 145 (2005) 1035-1044
12. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11 (1991) 563-583
13. Hou Y., Wu C.F., Yang J.Y., and Guo T. Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 1486-1495
14. 9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats. Neurotox Res 6 (2004) 153-158
15. Johns A. Psychiatric effects of cannabis. Br J Psychiatry; 178 (2001) 116-122
16. Johnson D.E., Nedza F.M., Spracklin D.K., Ward K.M., Schmidt A.W., Iredale P.A., et al. The role of muscarinic receptor antagonism in antipsychotic-induced hippocampal acetylcholine release. Eur J Pharmacol; 506 (2005) 209-219
17. Lichtman A.H., Dimen K.R., and Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology; 119 (1995) 282-290
18. 9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats. Behav Brain Res 166 (2006) 101-109
19. Mansbach R.S., Geyer M.A., and Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94 (1988) 507-514
20. Matsuda L.A., Bonner T.I., and Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327 (1993) 535-550
21. McGuire P.K., Jones P., Harvey I., Bebbington P., Toone B., Lewis S., et al. Cannabis and acute psychosis. Schizophr Res 13 (1994) 161-167
22. 9-tetrahydrocannabinol in rats. Jpn J Pharmacol 87 (2001) 297-308
23. 9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze. Life Sci 72 (2002) 397-407
24. 1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides 21 (2000) 1735-1742
25. 9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice. Pharmacol Biochem Behav 84 (2006) 330-336
26. Olton D.S., and Samuelson R.J. Remembrance of places past: spatial memory in rats. J Exp Psychol Anim Behav Process 2 (1976) 97-116
27. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, New York
28. Perry W., and Braff D.L. Information-processing deficits and thought disorder in schizophrenia. Am J Psychiatry 151 (1994) 363-367
29. Ranganathan M., and D'Souza D.C. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology 188 (2006) 425-444
30. Shirazi-Southall S., Rodriguez D.E., and Nomikos G.G. Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26 (2002) 583-594
31. Skosnik P.D., Spatz-Glenn L., and Park S. Cannabis use is associated with schizotypy and attentional disinhibition. Schizophr Res 48 (2001) 83-92
32. Swerdlow N.R., Braff D.L., Geyer M.A., and Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry 21 (1986) 23-33
33. Swerdlow N.R., and Geyer M.A. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 44 (1993) 741-744
34. Uchida S., Kato Y., Hirano K., Kagawa Y., and Yamada S. Brain neurotransmitter receptor-binding characteristics in rats after oral administration of haloperidol, risperidone and olanzapine. Life Sci 80 (2007) 1635-1640
35. Varty G.B., and Higgins G.A. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology 122 (1995) 15-26
36. Wolff M.C., and Leander J.D. Comparison of the effects of antipsychotics on a delayed radial maze task in the rat. Psychopharmacology 168 (2003) 410-416